Best private label cbd capsules manufacturers

Buyer criteria

• Market-specific Novel Food and THC compliance

  Confirm the manufacturer can supply and document for your exact target markets, since CBD ingestibles need a Novel Food route and THC limits differ by country. Ask which national markets they currently ship to and what dossier their extract sits behind. A partner vague on Novel Food status is a partner whose product you cannot legally sell.

• Per-batch cannabinoid and THC assay

  Require a Certificate of Analysis from an accredited lab for every finished batch, showing CBD content against label claim and THC below the relevant limit. Mislabelled potency is the defining problem in CBD, so a house that assays only the incoming extract and not the finished capsule cannot prove what is in the bottle.

• Isolate versus spectrum capability

  Verify the manufacturer runs the exact fill you need at scale. A hardshell isolate house quoting a full-spectrum softgel may subcontract the oil line. Confirm whether they handle powder, oil, or both, and ask for a sample of the same fill type and dose you intend to sell before committing to a run.

• Overage and stability for claimed dose

  Cannabinoids degrade, so the milligrams on the label must still be present at expiry. Ask how the manufacturer calculates overage and whether they hold stability data supporting the printed shelf life for your fill type. A dose assigned without stability backing risks under-potency complaints once product sits in distribution.

• Hemp contaminant screening

  Hemp can carry pesticides, heavy metals, and residual solvents from extraction. Confirm each batch is screened for these alongside microbiology, and that the extract supplier is qualified. In a daily-dose ingestible, contaminant testing is not optional, and a low extract price that skips it is a false economy.

Manufacturing process

1. 01

   Extract selection and cannabinoid verification

   The manufacturer selects CBD isolate, broad spectrum, or full spectrum extract and tests each incoming lot for cannabinoid content and THC level against specification. THC control is the gate, since exceeding a national limit makes the batch non-compliant. A Certificate of Analysis from an accredited lab travels with every extract lot.

2. 02

   Dose and excipient formulation

   The target CBD milligram dose per capsule is fixed, then carriers and excipients are chosen so the fill flows cleanly for powder isolate or stays stable for oil-based spectrum extract. Overage is calculated to ensure label-claim dose holds across shelf life, because cannabinoids degrade over time and the printed milligrams must survive to expiry.

3. 03

   Shell selection

   Isolate powder runs into a two-piece HPMC or gelatin hardshell, while broad or full spectrum oil needs a softgel or a liquid-filled banded hardshell on a different line. Shell choice locks the encapsulation tooling and the moisture barrier, which matters because oxidised extract loses potency and shifts colour.

4. 04

   Blending or oil preparation

   For isolate, the cannabinoid powder is blended with carriers to a validated uniformity so each capsule carries the same dose. For oil fills, the extract is warmed and combined with a carrier oil to a target concentration. Uniformity is verified before encapsulation so dose does not vary across the batch.

5. 05

   Encapsulation

   Hardshell powder is dosed by tamping pins or dosator and the capsule is locked, while softgels are formed and filled on a rotary die. In-process fill-weight or fill-volume checks confirm each unit carries the labelled CBD dose. Underfilled units are rejected, since dose accuracy is the core claim of a CBD capsule.

6. 06

   Quality control and cannabinoid assay

   Finished capsules are assayed for CBD content against label claim and for THC against the relevant national limit, alongside microbiological, heavy-metal, and pesticide screening that hemp material warrants. Per-batch CoAs document cannabinoid content and contaminants, and many brands publish them to build trust in a category dogged by mislabelling.

7. 07

   Bottling, sealing and lot coding

   Capsules are counted into bottles or blistered, fitted with a desiccant where needed, induction sealed for tamper evidence, capped, labelled, and lot coded. Labelling must match the assayed dose and carry the declarations each target market requires, with lot codes tracing finished units back to the extract lot for any compliance query.

Understanding cbd capsules private-label manufacturing

CBD capsules deliver a fixed dose of cannabidiol inside a swallowable hardshell or softgel, which removes the dosing guesswork and the hemp taste that put many consumers off oils and tinctures. For a private label brand this is the most credible CBD format to launch, because a capsule lets you state an exact milligram dose per unit and avoids the dropper variability that makes oils hard to standardize. The format also signals a supplement rather than a lifestyle product, which suits pharmacy and practitioner channels. The defining sourcing constraint is regulatory, not technical. CBD as an ingestible sits under Novel Food authorisation in the EU and Great Britain, so your contract manufacturer must work from a CBD isolate or distillate that has a credible Novel Food dossier route and that holds THC within the strict national limits, which differ market by market. A capsule that is legal in one country can be non-compliant a border away, so the first qualification question is which markets the manufacturer can actually supply and document, not the per-unit price. The fill decides the rest. CBD isolate is an odourless crystalline powder that encapsulates cleanly into a two-piece hardshell, often blended with a carrier and excipients. Broad or full spectrum extracts are oils, which need a softgel or a liquid-filled hardshell and a dedicated line. Isolate gives you precise dosing and zero THC, the safest compliance position. Spectrum oils carry the entourage marketing story but bring THC management, taste, and stability challenges. Lock isolate versus spectrum before you brief, because it determines which manufacturers can quote. Sourcing reality: CBD capsule contract manufacturing in Europe clusters in the Netherlands, Germany, Poland, and the UK, with most houses buying extract from specialist hemp processors rather than growing their own. MOQs for a custom dose typically start around 1,000 to 5,000 units because extract cost and GMP changeover dominate, with relabels of a stock dose possible lower. Lead times run 6 to 12 weeks and stretch when Certificates of Analysis or Novel Food documentation need refreshing. Cost is driven first by the CBD itself (isolate versus distillate, and the milligram dose per capsule), then the shell type, then excipients and the bottle. Private label CBD capsule buyers are wellness and sleep-focused D2C brands, pharmacy and drugstore private-label ranges, and practitioner and CBD-specialist retailers. Channel matters because pharmacy buyers demand full Novel Food and CoA documentation while D2C buyers move faster but carry the marketplace compliance risk themselves. Qualify a partner on documentation depth, per-batch cannabinoid assay, and THC control before flavour or shell aesthetics, since a capsule that overshoots a national THC limit becomes unsellable inventory overnight.

Frequently asked questions

Explore adjacent product types